They are both SC6 equivalent pricing.
Get with it.
AKE got a better price due to the contract structure, a lot of that ex GXY.
- Forums
- ASX - By Stock
- PLS
- Ann: September 2023 Quarterly Activities Presentation
Ann: September 2023 Quarterly Activities Presentation, page-24
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLS (ASX) to my watchlist
|
|||||
Last
$3.01 |
Change
-0.015(0.50%) |
Mkt cap ! $9.090B |
Open | High | Low | Value | Volume |
$3.02 | $3.04 | $3.00 | $11.42M | 3.757M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
26 | 218467 | $3.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.01 | 116283 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
25 | 260607 | 3.000 |
41 | 411140 | 2.990 |
35 | 373965 | 2.980 |
30 | 216998 | 2.970 |
40 | 390062 | 2.960 |
Price($) | Vol. | No. |
---|---|---|
3.010 | 71343 | 16 |
3.020 | 300075 | 28 |
3.030 | 326174 | 27 |
3.040 | 214174 | 22 |
3.050 | 264178 | 18 |
Last trade - 10.42am 16/07/2024 (20 minute delay) ? |
Featured News
PLS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online